Intestinal anti-inflammatory activity of coumarin and 4-hydroxycoumarin in the trinitrobenzenesulphonic acid model of rat colitis.

Coumarins represent an important class of phenolic compounds with multiple biological activities, including inhibition of lipidic peroxidation and neutrophil-dependent anion superoxide generation, anti-inflammatory and immunosuppressor actions. All of these proprieties are essential for that a drug may be used in the treatment of inflammatory bowel disease. The present study examined intestinal anti-inflammatory activity of coumarin and its derivative, the 4-hydroxycoumarin on experimental ulcerative colitis in rats. This was performed in two different experimental settings, i.e. when the colonic mucosa is intact or when the mucosa is in process of recovery after an initial insult. The results obtained revealed that the coumarin and 4-hydroxycoumarin, at doses of 5 and 25 mg/kg, significantly attenuated the colonic damage induced by trinitrobenzenesulphonic acid (TNBS) in both situations, as evidenced macroscopically, microscopically and biochemically. This effect was related to an improvement in the colonic oxidative status, since coumarin and 4-hydroxycoumarin prevented the glutathione depletion that occurred as a consequence of the colonic inflammation.

[1]  R. D. Murray.  The natural coumarins , 1982 .

[2]  W. Stenson,et al.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models , 1984 .

[3]  M. Anderson,et al.  Determination of glutathione and glutathione disulfide in biological samples. , 1985, Methods in enzymology.

[4]  H. Cooper,et al.  Immunohistologic study of ulcerative colitis with monoclonal antibodies against tumor-associated and/or differentiation antigens. , 1988, Gastroenterology.

[5]  J. Wallace,et al.  Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.

[6]  D. Egan,et al.  The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. , 1990, Drug metabolism reviews.

[7]  Tamaki Yamada,et al.  A comparative analysis of two models of colitis in rats. , 1992, Gastroenterology.

[8]  A. Zarzuelo,et al.  Flavonoid inhibition of enzymic and nonenzymic lipid peroxidation in rat liver differs from its influence on the glutathione-related enzymes. , 1995, Pharmacology.

[9]  W. Doe,et al.  Depleted mucosal antioxidant defences in inflammatory bowel disease. , 1995, Free radical biology & medicine.

[10]  C. Elson,et al.  Experimental models of inflammatory bowel disease. , 1995, Gastroenterology.

[11]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[12]  W. Strober.  Interactions between Epithelial Cells and Immune Cells in the Intestine , 1998, Annals of the New York Academy of Sciences.

[13]  A. Zarzuelo,et al.  Anti-Inflammatory Activity of Diosmin and Hesperidin in Rat Colitis Induced by TNBS , 1999, Planta medica.

[14]  H. Sies,et al.  Glutathione and its role in cellular functions. , 1999, Free radical biology & medicine.

[15]  H. Vapaatalo,et al.  Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant/prooxidant properties. , 1999, Free radical biology & medicine.

[16]  C. Fiocchi,et al.  Pathogenesis of inflammatory bowel disease. , 1999, Current opinion in gastroenterology.

[17]  E. Mazzon,et al.  Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis. , 2000, European journal of pharmacology.

[18]  A. García-Argáez,et al.  Anti-inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. , 2000, Planta medica.

[19]  D. Podolsky.  Pride and prejudice: inflammatory bowel disease models and drug development. , 2000, Current opinion in gastroenterology.

[20]  S. Hanauer,et al.  Comparative Tolerability of Treatments for Inflammatory Bowel Disease , 2000, Drug safety.

[21]  E. Crespo,et al.  Effects of Silymarin on the Acute Stage of the Trinitrobenzenesulphonic Acid Model of Rat Colitis , 2001, Planta medica.

[22]  M. Repetto,et al.  Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[23]  M. Grisham,et al.  Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. , 2002, Free radical biology & medicine.

[24]  C. Loguercio,et al.  Glutathione supplementation improves oxidative damage in experimental colitis. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[25]  A. Orjales,et al.  Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats. , 2003, European journal of pharmacology.

[26]  W. Kirch,et al.  Homocysteine, Cysteine, and Glutathione in Human Colonic Mucosa: Elevated Levels of Homocysteine in Patients with Inflammatory Bowel Disease , 2003, Digestive Diseases and Sciences.

[27]  M. Comalada,et al.  Preventative Effects of Lactulose in the Trinitrobenzenesulphonic Acid Model of Rat Colitis , 2005, Inflammatory bowel diseases.

[28]  C. Loguercio,et al.  Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats , 1996, Digestive Diseases and Sciences.

[29]  P. Lorite,et al.  A new approach using tissue alkaline phosphatase histochemistry to identify Crohn's disease. , 2007, Pathology, research and practice.